Abstract: A functional fluid for the removal of contaminates such as but not limited to, acid causing components in gas, sulfur components and carbon oxides from fluid streams, and removal and treatment of NOX & SOX from post combustion emissions. Also described is the manufacturing process to produce the functional fluid both in a batch atmospheric process system as well as a closed system capable of operating at above or below atmospheric conditions.

Abstract: This invention is directed to compounds of formula (I): where r, q, R, R2, R3, R4, R5a, R5b, R5c, R6a, R6b, R6c, R7, R8, and R9 are described herein, as single stereoisomers or as mixtures of stereoisomers, or pharmaceutically acceptable salts, solvates, clathrates, polymorphs, ammonium ions, N-oxides or prodrugs thereof; which are leukotriene A4 hydrolase inhibitors and therefore useful in treating inflammatory disorders. Pharmaceutical compositions comprising the compounds of the invention and methods of preparing the compounds of the invention are also disclosed.

Abstract: Apparatus and method for enhancing solubility of a solute in a solvent, the apparatus comprising a solvent and/or solute inlet (104) having a fluidizing unit which creates a vortex such that a fluids interfacial/boundary layer exists within the vortex where enhanced mass transfer, or dissolution of solute into the solvent takes place.

Abstract: This invention is directed to compounds of formula (I): where r, q, R, R2, R3, R4, R5a, R5b, R5c, R6a, R6b, R6c, R7, R8, and R9 are described herein, as single stereoisomers or as mixtures of stereoisomers, or pharmaceutically acceptable salts, solvates, clathrates, polymorphs, ammonium ions, N-oxides or prodrugs thereof; which are leukotriene A4 hydrolase inhibitors and therefore useful in treating inflammatory disorders. Pharmaceutical compositions comprising the compounds of the invention and methods of preparing the compounds of the invention are also disclosed.

Abstract: A separator for separating a multiphase mixture comprising a pressure vessel supported for rotation within a casing containing a gas which may be held at an elevated temperature or pressure. A plurality of vanes is disposed within the pressure vessel. The pressure vessel has an inlet, a first phase outlet and a plurality of second phase outlets disposed radially outwardly of the first phase outlet with respect to a separator axis. A regulator is provided in the form of pressure-activated nozzles to regulate flow through the second phase outlets. In use, a mixture of solids and liquid is fed into the pressure vessel and the pressure vessel is spun within the gas causing solids to accumulate in the vicinity of the second phase outlets. The pressure-activated nozzles are repeatedly opened and closed to expel the accumulated solids.

Abstract: A functional fluid for the removal of contaminates such as but not limited to, acid causing components in gas, sulfur components and carbon oxides from fluid streams, and removal and treatment of NOX & SOX from post combustion emissions. Also described is the manufacturing process to produce the functional fluid both in a batch atmospheric process system as well as a closed system capable of operating at above or below atmospheric conditions.

Abstract: A functional fluid for the removal of contaminates such as but not limited to, acid causing components in gas, sulfur components and carbon oxides from fluid streams, and removal and treatment of NOX & SOX from post combustion emissions. Also described is the manufacturing process to produce the functional fluid both in a batch atmospheric process system as well as a closed system capable of operating at above or below atmospheric conditions.

Abstract: This invention is directed to compounds of formula (I): where r, q, R, R2, R3, R4, R5a, R5b, R5c, R6a, R6b, R6c, R7, R8, and R9 are described herein, as single stereoisomers or as mixtures of stereoisomers, or pharmaceutically acceptable salts, solvates, clathrates, polymorphs, ammonium ions, N-oxides or prodrugs thereof; which are leukotriene A4 hydrolase inhibitors and therefore useful in treating inflammatory disorders. Pharmaceutical compositions comprising the compounds of the invention and methods of preparing the compounds of the invention are also disclosed.

Abstract: Apparatus for inhibiting fines carryover in the form of a settlement tank comprising: a filter which divides the tank into upper and lower portions; a fluid inlet in the lower portion for admitting into the tank a fluid with entrained solids; and a fluid outlet in the upper portion through which filtered fluid can leave the tank. The filter comprises filter media supported on a permeable wall, the wall including a filter media outlet which is normally closed, and opening means for opening the filter media outlet to allow the filter media to discharge into the lower portion of the tank. The invention also relates to a method of refilling the filter with filter media.

Abstract: A radial or crossflow media filter comprising a housing such as a vessel or tank (1), the housing containing filter media (9), a contaminated flow inlet (2) and a discharge outlet (8), the inlet comprising a manifold (5) situated within the housing, the manifold (5) having flow outlets (6) which are directed laterally, away from the discharge outlet (8). The flow inlet may comprise a substantially vertically aligned elongate tubular manifold (5) with a plurality of flow distribution holes or slots disposed along its length. Furthermore, the discharge outlet (8) may be accessed through a chamber within the housing which contains a second filter media (11) which is of larger average particle size than the first filter media (9).

Abstract: Apparatus for transferring settled or suspended solids from an open vessel into a closed vessel, the apparatus comprising a suction line which extends from the closed vessel to the open vessel via drive means, such as a pump or compressor, and a solids feed line which extends from a solids outlet in the open vessel to a solids inlet in the closed vessel, a fluidising apparatus being provided to fluidise the solids in the open vessel.

Abstract: This invention is directed to lipoxin A4 analogs of the following formula (I) and (II): wherein R1, R2, R3, R4 and R5 are described herein. These analogs are useful in treating inflammatory and autoimmune disorders in humans. These analogs are also useful in treating pulmonary or respiratory tract inflammation in humans.

Abstract: An endovascular stent, including: a guide portion and a drive portion; a plurality of flexible support arms, each including two opposing ends that are coupled to said guide portion and said drive portion respectively, said arms being moveable relative to each other between an expanded position and a compressed position; and said stent including at least one barrier portion, such that when said arms are moved to said expanded position, said arms configure the barrier portion into a selectively permeable barrier through which one or more articles may be introduced into a space between said barrier and a wall of a lumen receiving said stent.

Abstract: The invention relates to peptides from Prostatic Acid Phosphatase (PAP), especially those identified as PAP.135 and PAP.161. The nucleic acid molecules encoding the peptides, antibodies against the peptides, and the use of such peptides, nucleic acids and antibodies in immunotherapy, vaccines and assays are also included in the scope of the invention.

Abstract: Apparatus for inhibiting fines carryover in the form of a settlement tank comprising: a filter which divides the tank into upper and lower portions; a fluid inlet in the lower portion for admitting into the tank a fluid with entrained solids; and a fluid outlet in the upper portion through which filtered fluid can leave the tank. The filter comprises filter media supported on a permeable wall, the wall including a filter media outlet which is normally closed, and opening means for opening the filter media outlet to allow the filter media to discharge into the lower portion of the tank. The invention also relates to a method of refilling the filter with filter media.

Abstract: This invention is directed to compounds of formula (I): where r, q, R, R2, R3, R4, R5a, R5b, R5c, R6a, R6b, R6c, R7, R8, and R9 are described herein, as single stereoisomers or as mixtures of stereoisomers, or pharmaceutically acceptable salts, solvates, clathrates, polymorphs, ammonium ions, N-oxides or prodrugs thereof; which are leukotriene A4 hydrolase inhibitors and therefore useful in treating inflammatory disorders. Pharmaceutical compositions comprising the compounds of the invention and methods of preparing the compounds of the invention are also disclosed.

Abstract: This invention is directed to compounds of formula (I): where r, q, R, R2, R3, R4, R5a, R5b, R5c, R6a, R6b, R6c, R7, R8, and R9 are described herein, as single stereoisomers or as mixtures of stereoisomers, or pharmaceutically acceptable salts, solvates, clathrates, polymorphs, ammonium ions, N-oxides or prodrugs thereof; which are leukotriene A4 hydrolase inhibitors and therefore useful in treating inflammatory disorders. Pharmaceutical compositions comprising the compounds of the invention and methods of preparing the compounds of the invention are also disclosed.

Abstract: Apparatus for inhibiting fines carryover in the form of a settlement tank comprising: a filter which divides the tank into upper and lower portions; a fluid inlet in the lower portion for admitting into the tank a fluid with entrained solids; and a fluid outlet in the upper portion through which filtered fluid can leave the tank. The filter comprises filter media supported on a permeable wall, the wall including a filter media outlet which is normally closed, and opening means for opening the filter media outlet to allow the filter media to discharge into the lower portion of the tank. The invention also relates to a method of refilling the filter with filter media.

Abstract: A cyclone separator (40) includes a housing (42), in which a cyclone assembly (10) is contained. The housing (42) has an inflow chamber (44), an overflow chamber (46) and a discharge chamber (48). The cyclone assembly (10) has an inner cyclone liner (16) positioned concentrically within a cyclone chamber (12). A displacement means (52) is provided for displacing the inner cyclone liner (16) axially from an operative position in the cyclone chamber (12) to an inoperative position in the overflow chamber (46) of the housing (42). The cyclone chamber (12) has a larger internal diameter than the inner cyclone liner (16), therefore, when the inner cyclone liner is moved to the inoperative position, the flowrate through the cyclone assembly is increased.

Abstract: A radial or crossflow media filter comprising a housing such as a vessel or tank (1), the housing containing filter media (9), a contaminated flow inlet (2) and a discharge outlet (8), the inlet comprising a manifold (5) situated within the housing, the manifold (5) having flow outlets (6) which are directed laterally, away from the discharge outlet (8). The flow inlet may comprise a substantially vertically aligned elongate tubular manifold (5) with a plurality of flow distribution holes or slots disposed along its length. Furthermore, the discharge outlet (8) may be accessed through a chamber within the housing which contains a second filter media (11) which is of larger average particle size than the first filter media (9).